NASDAQ · Healthcare · Biotechnology
Artiva Biotherapeutics, Inc.
ARTV
Artiva Biotherapeutics, Inc. CEO Fred Aslan · Market cap $169.3M.
$6.85
-0.83 · -10.81%
52w hi $14.5352w lo $1.47
Off 52w high 47.6%
78
STRONG
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
3
1 strong · 2 notable
Analyst consensus
Strong Buy
Avg PT $37.50
Section 01
Recent Form 4 filings
3 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 11 | GC Corp. | Buy | 347,222 | $11.52 | +$4.00M | 70 | |
| May 11 | GC Corp. | Buy | 1,085,069 | $11.52 | +$12.50M | 73 | |
| May 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,510,416 | $11.52 | +$75.00M | 78 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JulAugSepOctNovDecJanFebMarAprMayJun